Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 582 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Back
 Table of Contents
 
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed752    
    Printed37    
    Emailed0    
    PDF Downloaded55    
    Comments [Add]    

Recommend this journal

 
ARTICLE
Year : 1991  |  Volume : 33  |  Issue : 2  |  Page : 108-112

Pharmacokinetics of Nitroxazepine in Depressed Patients


1 Medical Department, Hindustan CIBA-Geigy Limited, Bombay, India
2 Department of Psychiatry, K.E.M. Hospital, Bombay, India
3 Drug Metabolism Department, Hindustan CIBA-Geigy Limited, Bombay, India
4 Clinical Pharmacology Unit, KEM Hospital, Bombay, India

Correspondence Address:
A D Bhatt
Medical Department, Hindustan CIBA-Geigy Limited, Bombay
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 21897465

Rights and PermissionsRights and Permissions

A pharmacokinetic study was done on 10 depressed patients (DSM-III-R 296.3). The patients were treated with Sintamil (R) (nitroxazepine HCl) with titrated dose from 75 mg to 225 mg for 6 weeks. Plasma levels of nitroxazepine (Sintamil (R)) and its metabolites desmethyl (D), N-oxide (N-O) and carboxylic acid (c) were estimated. Anti-depressant efficacy was judged by reduction in Hamilton Rating Depression Scale (HDRS) scores, and tolerability was monitored by reports of unwanted effects. The overall reduction in HDRS score was about 50% by 6 weeks. The plasma levels of nitroxazepin (ng/ral) showed a rise from a mean ( +SEM) level. 47.0 4-7.3 on day 1 (dose 75 mg) to 129.84-24.6 on day 7 (dose 150 mg) (p<0.01) and remained steady till day 21. There were large interindividual variations. The metabolites followed a similar pattern. The HDRS score showed a steady reduction between day 14 and 42 when the levels of nitroxizepine and des-methyl metabolites were maintained between 176.5 ng/ml to 251 ng/ml.



[PDF]*

        

Print this article         Email this article